Guest editorial: The rise and fall of PC-SPES: New generation of herbal supplement, adulterated product, or new drug?

Integrative Cancer Therapies

Volumn 1, Issue 3, 2002, Pages 266-270

  Blumenthal, Mark ^a  

^a American Botanical Council   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CHINESE DRUG; DIETHYLSTILBESTROL; HERBACEOUS AGENT; NEW DRUG; PC SPES; PROSTATE SPECIFIC ANTIGEN; SABAL EXTRACT; WARFARIN; ANTINEOPLASTIC AGENT; HERBAL PREPARATION PC SPES; HERBAL PREPARATION PC-SPES;

BLEEDING; CANCER RADIOTHERAPY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; CHEMISTRY; DRUG CONTAMINATION; PROSTATE TUMOR;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHEMISTRY, PHARMACEUTICAL; DIETARY SUPPLEMENTS; DRUG CONTAMINATION; DRUGS, CHINESE HERBAL; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 1542394734     PISSN: 15347354     EISSN: None     Source Type: Journal    
DOI: 10.1177/153473540200100311     Document Type: Editorial

References (18)

1. Oh WK, George DJ, Hackmann K, et al. Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer. Urology. 2001;57:122-126.
2. de la Taille A, Buttyan R, Hayek O, et al. Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. J Urol. 2000;164:1229-1234.
3. Pfeifer BL, Pirani JF, Hamann SR, et al. PC-SPES, a dietary supplement for the treatment of hormone refractory prostate cancer. Br J Urol Int. 2000;85:481-485.
4. Small EJ, Frohlich MW, Bok R, et al. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol. 2000;18:3595-3603.
5. Di Paola RS, Zhang H, Lambert GH, et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. New Engl J Med. 1998;339:785-791.
6. National Prostate Cancer Coalition. PCa community. Retrieved May 15, 2002, from http://www.4npcc.org
7. Chen S. In vitro mechanism of PC SPES. Urology. 2001;58(2 suppl 1):28-35.
8. Chen S. PC-SPES: historical and scientific highlights. Paper presented at: PC-SPES Roundtable Conference, Urological Sciences Research Foundation; Oct 15, 2001; Los Angeles, CA.
9. Marks LS, DiPaola RS, Nelson P, et al. PC-SPES: potent herbal formulation for prostate cancer. Urology. 2002.
10. Burton TM. Recall of herbal supplement highlights gaps in regulation. Wall Street Journal. March 26, 2002.
11. Sovak M, Seligson AL, Kona M, et al. PC-SPES in prostate cancer: an herbal mixture currently containing warfarin and previously diethylstilbestrol and indomethacin. Paper presented at: American Association for Cancer Research Annual Meeting; Apr 8, 2002; San Francisco, CA.
12. Schiff JD, Ziecheck WS, Choi B. Pulmonary embolus related to PC-SPES use in a patient with PSA recurrence after radical prostatectomy. Urology. 2002;59:444.
13. Lock M, Loblaw DA, Choo R, Imrie K. Disseminated intravascular coagulation and PC-SPES: a case report and literature review. Can J Urol. 2001;8:1326-1329.
14. Weinrobe MC, Montgomery B. Acquired bleeding diathesis in a patient taking PC-SPES. N Engl J Med. 2001;345:1213-1214.
15. California Department of Health Services. State health director warns consumers about prescription drugs in herbal products. California Department of Health Services Food and Drug Branch, No. 02-03. Retrieved February 7, 2002, from http://www.dhs.ca.gov
16. McCaleb R, Blumenthal M. Black pearls lose their luster: prescription drugs masquerade as Chinese herbal arthritis formula. HerbalGram. 1990;22:38-39.
17. Moss R. PC SPES was adulterated. Weekly CancerDecisions.com Newsletter. Retrieved April 16, 2002, from www.cancerdecisions.com
18. Cordell GA. PC-SPES: a brief overview. Integrative Cancer Ther. 2002;1:267-282.